Auteurs
Checkpoint
Ncbi
Racine
Checkpoint
Ncbi
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (Ncbi)

Index « Auteurs » - entrée « Masao Nawata »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Masao Nakasatomi < Masao Nawata < Masao Seto  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 5.
Ident.Authors (with country if any)Title
000061 (2007) Yosuke Okada ; Masao Nawata ; Yoshiya Tanaka[Efficacy of anti-cytokines and anti-RANKL antibody for treatment of RA and osteoporosis].
000415 (2011) Tsutomu Takeuchi [Japon] ; Yoshiya Tanaka ; Koichi Amano ; Daisuke Hoshi ; Masao Nawata ; Hayato Nagasawa ; Eri Sato ; Kazuyoshi Saito ; Yuko Kaneko ; Shunsuke Fukuyo ; Takahiko Kurasawa ; Kentaro Hanami ; Hideto Kameda ; Hisashi YamanakaClinical, radiographic and functional effectiveness of tocilizumab for rheumatoid arthritis patients--REACTION 52-week study.
000949 (2014) Ippei Miyagawa [Japon] ; Shingo Nakayamada ; Kazuyoshi Saito ; Kentaro Hanami ; Masao Nawata ; Norifumi Sawamukai ; Kazuhisa Nakano ; Kunihiro Yamaoka ; Yoshiya TanakaStudy on the safety and efficacy of tocilizumab, an anti-IL-6 receptor antibody, in patients with rheumatoid arthritis complicated with AA amyloidosis.
000951 (2014) Yoshiya Tanaka [Japon] ; Tsutomu Takeuchi ; Koichi Amano ; Kazuyoshi Saito ; Kentaro Hanami ; Masao Nawata ; Shunsuke Fukuyo ; Hideto Kameda ; Yuko Kaneko ; Takahiko Kurasawa ; Hayato Nagasawa ; Daisuke Hoshi ; Eri Sato ; Hisashi YamanakaEffect of interleukin-6 receptor inhibitor, tocilizumab, in preventing joint destruction in patients with rheumatoid arthritis showing inadequate response to TNF inhibitors.
002218 (2019) Yuya Fujita [Japon] ; Masao Nawata [Japon] ; Atsushi Nagayasu [Japon] ; Kazuki Someya [Japon] ; Kazuyoshi Saito [Japon] ; Yoshiya Tanaka [Japon]Fifty-Two-Week Results of Clinical and Imaging Assessments of a Patient with Rheumatoid Arthritis Complicated by Systemic Sclerosis with Interstitial Pneumonia and Type 1 Diabetes despite Multiple Disease-Modifying Antirheumatic Drug Therapy That Was Successfully Treated with Baricitinib: A Novel Case Report

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i -k "Masao Nawata" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i  \
                -Sk "Masao Nawata" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Masao Nawata
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021